share_log

Alaunos Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Oct 27, 2020 16:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more